InsidersTradesSigma
Follow the 텔콘RF제약 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 텔콘RF제약 has recorded 33 insider filings. Market capitalisation: €15.3bn. The latest transaction was disclosed on 16 July 2026 (Other). Among the most active insiders: 뉴온. The full history is free.
33
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
13 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,438 of 29,024 companies
9.9
score / 100
Value8
Quality12
FCF yld-22%
Earn yld-43%
EV/EBITDA·
ROE-17%
Gross mgn8.6%
Net mgn-10%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 July 2026
Declarations33 total
2,329,916 sharesKRXDART:20260716000738
2,989,916 sharesShareKRXDART:20260716000723
25 of 33 declarations
About 텔콘RF제약
텔콘RF제약 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative pharmaceutical products.